Cargando…
Growth hormone and nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a prevalent cause of liver disease and metabolic comorbidities. Obesity is strongly associated with NAFLD and is also a state of relative deficiency of growth hormone (GH). Evidence supports a role of reduced GH and insulin-like growth factor-1 (IGF-1) in...
Autores principales: | Ma, Ingrid L., Stanley, Takara L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373851/ https://www.ncbi.nlm.nih.gov/pubmed/37520312 http://dx.doi.org/10.1097/IN9.0000000000000030 |
Ejemplares similares
-
Growth Hormone Releasing Hormone Reduces Plasma Markers of Immune Activation and Hepatic Immune Pathways in Nonalcoholic Fatty Liver Disease
por: Stanley, Takara Leah, et al.
Publicado: (2021) -
Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Yang, Meng, et al.
Publicado: (2021) -
Risk factors in nonalcoholic fatty liver disease
por: Ko, Eunji, et al.
Publicado: (2023) -
Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children
por: Alisi, Anna, et al.
Publicado: (2011) -
Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)